Far Infrared Theraphy on Peripheral Arterial Disease in Hemodialysis Patients.

Far Infrared Theraphy on Peripheral Arterial Disease in Hemodialysis Patients. - FIT on PAD in HD patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016680

Enrollment

Registered

2015-03-07

Start date

2015-03-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PAD in Hemodialysis patients

Interventions

Far Infrared theraphy (WS Far Infrared Medical Technology Co.,Ltd., Taipei, Taiwan)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: continuing more than one year on Hemodialysis

Exclusion criteria

Exclusion criteria: blood clotting defect

Design outcomes

Primary

Measure	Time frame
skin perfusion pressure	—

Secondary

Measure	Time frame
diminution rate of skin ulcer ankle-brachial-index duration of hospitalization	—

Countries

Japan

Contacts

Public ContactHiroaki Io

Juntendo University Nephrology

hiroaki@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026